WO1998011853A1 - Composition and method for acceleration of wound and burn healing - Google Patents
Composition and method for acceleration of wound and burn healing Download PDFInfo
- Publication number
- WO1998011853A1 WO1998011853A1 PCT/US1997/016732 US9716732W WO9811853A1 WO 1998011853 A1 WO1998011853 A1 WO 1998011853A1 US 9716732 W US9716732 W US 9716732W WO 9811853 A1 WO9811853 A1 WO 9811853A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wound
- composition
- bioactive glass
- healing
- topical antibiotic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C4/00—Compositions for glass with special properties
- C03C4/0007—Compositions for glass with special properties for biologically-compatible glass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Definitions
- the present invention relates to a treatment composition and method for the accelerated healing of wounds and burns. More specifically, the present invention relates to the combination and use of particles of bioactive
- the present invention also relates to a topical antibiotics.
- a treatment composition and method for the accelerated healing of wounds and burns including the combination of bioactive glass, one or more topical
- Tissue damage is not restricted to the initial area of injury, it may increase over the next several hours or days as a result of the release of lysomal enzymes from the injured
- Coagulation the first phase of the healing process, bridges the gap between the injury and the inflammatory response, the second phase of wound
- fibrin formation The result of the activation of either of the two coagulation pathways is the generation of thrombin, which in turn catalyzes the conversion of fibrinogen to fibrin monomer. Fibrin monomer spontaneously
- the fibrin fibers are
- Fibrin stabilizing factor which is generated from its proenzyme by thrombin,
- fibronectin The platelet surfaces are heavily coated, and each looks like a
- the second phase of wound repair is the inflammatory response, which
- Histamine and serotonins act to increase capillary dilation, opening previously
- vasodilation produced by the factors just discussed causes a widening of the
- Control of infection at the wound site is of critical importance in successful wound repair. Infections delay healing, enlarge the wound lesion, may lead to systemic infection, and greatly increase the likelihood of
- PMN's polymorphonuclear leukocytes
- Fibronectin facilitates the attachment of the bacterium to the membrane of the phagocyte.
- Macrophages are primarily responsible for the clearance of wound debris.
- Wound macrophages like wound PMN's are actively phagocytic. They
- the fibrin clot itself is
- the fragments are removed by lymphatic drainage and thus enter the circulation.
- These soluble complexes are removed by the sessile cells of the RES, primarily those of the spleen and liver. Also, PMN's trapped in the clot
- PMN's enzymes by PMN's may be considered beneficial to the host in most cases, they may also increase tissue destruction and delay healing. If the PMN's
- fibroblasts including those at
- the proliferating fibroblasts derive part of their nutrients from the components of tissue debris and cells released by macrophages.
- the fibroblast phase may last 2 to 4 weeks in a
- Fibroblasts as the macrophages did, use the fibers of the fibrin
- Angiogenesis begins with the growth of capillary buds into the area directly behind the fibroblasts. In the early phases of
- the capillaries are much more numerous than in normal tissue
- the capillaries are very leaky, which facilitates the movement of cells and macromolecule into the wound site.
- capillaries originating from the other sides and fuse, reestablishing complete circulation within the wound.
- the collagen molecule is synthesized on
- the membrane of the endoplastic reticulum undergoes extensive postranslational modification, hydroxylation, glycosylation, and further steps - to form the procollagen molecule.
- the procollagen molecule is then secreted
- the collagen network in effect replaces the fibrin clot as the major
- Reepithelialization begins to occur within a few hours of injury as the
- Remodeling is the last step of wound healing. Scar tissue continues to gain tensile strength for several months after collagen content stabilizes. This
- Collagen accumulation is the sum of synthesis and destruction, and both occur simultaneously during the wound healing process. After about 14 days, a balance between collagen
- the collagenase involved in the remodeling comes from epithelial cells, from fibroblasts encountering new epithelium, and from macrophages that contain collagenase in their lysosomes.
- Typical wound healing takes anywhere from 5 to 21 days. This time period is of course longer for the immune compromised patient because such
- limbs have continuous injury at the point of contact between the limb and the
- collagen matrix beads having an average pore size of from 50 to 350 microns, and the collagen comprising from 1 to 30% by volume of the
- the collagen matrix is sufficiently open to stimulate cellular ingrowth therethrough and yet sufficiently stiff and non-compressible to fill and protect
- the formulation is also sufficiently moisture and gas permeable to
- composition and method capable of dramatically enhancing the time required
- the present invention is directed to a method for treating wounds including contacting a wound with an effective wound healing amount of bioactive glass and topical antibiotic.
- the present invention is also directed to
- composition for the accelerated healing of wounds and burns including
- the present invention is further directed to a method for grafting skin including applying bioactive glass to a graft and then placing the graft.
- Figure 1 is a photograph of a wound in patient with vasculitis taken soon after the wound was inflicted before treatment with a composition in
- Figure 2 is a photograph of the same wound of Figure 1 after treatment with a composition in accordance with the present invention taken 4 days after the photograph of Figure 1.
- Figure 3 is a photograph of the same wound of Figure 2 taken 7 days after the photograph of Figure 2.
- Figure 4 is a photograph of the same wound of Figure 2 taken 7 days
- bioactive glass and a topical antibiotic yields a composition which is capable
- compositions by weight percentage typically have the following composition by weight percentage:
- the preferred composition of the bioactive glass is:
- the preferred particle size range for the bioactive glass is small and
- Topical antibiotics are antibiotics suitable for skin treatment.
- antibiotics examples include: chloramphenicol, chlortetracycline,
- gentamicin mafenide, mupiroicin, neomycin, polymyxin B, bacitracin, silver
- bioactive glass and topical antibiotic can be combined in any combination.
- composition of the present invention can be combined with an
- bioactive glass and topical antibiotic of the present invention with other
- wound and burn treatments or dressings such as collagen, fibrin, fibronectin, vitamin E, gauze, cotton, cellulosic, synthetic wound or burn dressings and
- Dressings of fiberglass and fiberglass made from fibers of bioactive glass can also be used.
- the present invention is also directed to a method for grafting skin
- the graft may also be further treated with a topical antibiotic prior to placement.
- the application of bioglass to grafts is intended to increase the likelihood that the graft will "take” and incorporate in
- bioactive glass e.g. from 0.5 m 2 /g initially to over 50 m 2 /g by 12 hours which attracts collagen, fibronectin and cells.
- the bioactive glass e.g. from 0.5 m 2 /g initially to over 50 m 2 /g by 12 hours
- wounds or burns healed with the composition or method of the present invention heal without
- the present invention is also directed to the incorporation of the bioactive paniculate glass and a topical
- a two part mixing syringe with two separate storage chambers and a mixing chamber can be used to mix the bioactive glass and topical antibiotic in a two part system wherein the bioactive glass and topical antibiotic are mixed and simultaneously applied.
- a two part mixing syringe with two separate storage chambers and a mixing chamber can be used to mix the bioactive glass and topical antibiotic in a two part system.
- paniculate bioactive glass can be incorporated into a bandage and the topical antibiotic can be applied to the wound or burn which is followed by application of the bandage.
- Other two part delivery systems are known to those of ordinary skill in the art.
- Figure 1 is a photograph of a wound in patient with vasculitis taken soon after the wound was inflicted before treatment with a composition in
- This wound was treated with a
- a diabetic suffering from delayed healing lesions was treated with a mixture of particulate bioactive glass of less than 40 ⁇ and an equal volume of
- NEOSPORINTM The mixture was applied directly to the delayed healing lesions of about 1/2 cm by 1/2 cm. These lesions normally remain non- healing for over 14 days. The mixture was applied twice a day.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69738693T DE69738693D1 (en) | 1996-09-19 | 1997-09-19 | ON WOUND AND FIRE Healing |
AU43566/97A AU4356697A (en) | 1996-09-19 | 1997-09-19 | Composition and method for acceleration of wound and burn healing |
EP97941714A EP1021148B1 (en) | 1996-09-19 | 1997-09-19 | Composition and method for acceleration of wound and burn healing |
JP51492898A JP2001503739A (en) | 1996-09-19 | 1997-09-19 | Compositions and methods for promoting wound and burn healing |
HK99103555A HK1018394A1 (en) | 1996-09-19 | 1999-08-16 | Composition for acceleration of wound and burn healing as well as a wound or burn dressing |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/715,911 US5834008A (en) | 1996-09-19 | 1996-09-19 | Composition and method for acceleration of wound and burn healing |
US08/715,911 | 1996-09-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998011853A1 true WO1998011853A1 (en) | 1998-03-26 |
Family
ID=24875977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/016732 WO1998011853A1 (en) | 1996-09-19 | 1997-09-19 | Composition and method for acceleration of wound and burn healing |
Country Status (9)
Country | Link |
---|---|
US (2) | US5834008A (en) |
EP (1) | EP1021148B1 (en) |
JP (1) | JP2001503739A (en) |
CN (1) | CN1303953C (en) |
AT (1) | ATE395022T1 (en) |
AU (1) | AU4356697A (en) |
DE (1) | DE69738693D1 (en) |
HK (1) | HK1018394A1 (en) |
WO (1) | WO1998011853A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000015167A1 (en) * | 1998-09-10 | 2000-03-23 | Usbiomaterials Corporation | Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
EP1049457A1 (en) * | 1998-01-23 | 2000-11-08 | Usbiomaterials Corporation | Bioactive glass treatment of inflammation in skin conditions |
EP1185247A1 (en) * | 1999-04-29 | 2002-03-13 | Usbiomaterials Corporation | Anti-inflammatory bioactive glass particulates |
US6428800B2 (en) | 1996-09-19 | 2002-08-06 | Usbiomaterials Corporation | Composition and method for acceleration of wound and burn healing |
US6482444B1 (en) | 1999-06-14 | 2002-11-19 | Imperial College Innovations | Silver-containing, sol/gel derived bioglass compositions |
WO2002102430A1 (en) * | 2001-06-14 | 2002-12-27 | Universidad Complutense De Madrid Rectorado | Method for producing bioactive implants that are used as systems for the controlled release of antibiotics |
JP2004500404A (en) * | 2000-03-27 | 2004-01-08 | カール − ツァイス − シュティフツング | Novel cosmetic, body care, cleansing and nutritional supplement compositions containing bioactive glass and methods of manufacture and use thereof |
US6756060B1 (en) * | 1996-09-19 | 2004-06-29 | Usbiomaterials Corp. | Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
JP2007507426A (en) * | 2003-09-29 | 2007-03-29 | ショット アクチエンゲゼルシャフト | Tissue abrasive |
WO2007072065A2 (en) * | 2005-12-23 | 2007-06-28 | Advanced Bio-Technologies, Inc. | Silicone composition |
US7628997B1 (en) | 1999-07-09 | 2009-12-08 | Schott Ag | Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8801681B2 (en) | 1995-09-05 | 2014-08-12 | Argentum Medical, Llc | Medical device |
US6861570B1 (en) | 1997-09-22 | 2005-03-01 | A. Bart Flick | Multilayer conductive appliance having wound healing and analgesic properties |
US7214847B1 (en) | 1997-09-22 | 2007-05-08 | Argentum Medical, L.L.C. | Multilayer conductive appliance having wound healing and analgesic properties |
US5814094A (en) | 1996-03-28 | 1998-09-29 | Becker; Robert O. | Iontopheretic system for stimulation of tissue healing and regeneration |
US8455710B2 (en) | 1997-09-22 | 2013-06-04 | Argentum Medical, Llc | Conductive wound dressings and methods of use |
US6517863B1 (en) * | 1999-01-20 | 2003-02-11 | Usbiomaterials Corporation | Compositions and methods for treating nails and adjacent tissues |
US6383519B1 (en) * | 1999-01-26 | 2002-05-07 | Vita Special Purpose Corporation | Inorganic shaped bodies and methods for their production and use |
EP1176991B1 (en) * | 1999-05-12 | 2006-03-22 | D & E Cryo CC | Ceramic wound treatment device |
CA2378648A1 (en) * | 1999-07-09 | 2001-01-18 | Carl-Zeiss-Stiftung Trading As Schott Glas | Non-toxic, microbicidal detergent |
US6046160A (en) * | 1999-07-22 | 2000-04-04 | Deroyal Industries, Inc. | Composition and method for enhancing wound healing |
US6458162B1 (en) * | 1999-08-13 | 2002-10-01 | Vita Special Purpose Corporation | Composite shaped bodies and methods for their production and use |
WO2001072145A1 (en) | 2000-03-24 | 2001-10-04 | Ustherapeutics, Llc | Nutritional supplements formulated from bioactive materials |
ATE332879T1 (en) * | 2001-08-22 | 2006-08-15 | Schott Ag | ANTIMICROBIAL, ANTI-INFLAMMATORY, WOUND-HEALING GLASS POWDER AND USE THEREOF |
DE10141117A1 (en) * | 2001-08-22 | 2003-03-13 | Schott Glas | Antimicrobial silicate glass and its use |
DE10293767B4 (en) * | 2001-08-22 | 2017-06-08 | Schott Ag | Disinfectant glass powder with antimicrobial, anti-inflammatory, wound-healing effect and its use |
EP1469865A4 (en) | 2001-12-31 | 2010-04-14 | Crosslink D Inc | Hemostatic compositions and methods for controlling bleeding |
US20040001878A1 (en) * | 2002-06-26 | 2004-01-01 | Deroyal Industries, Inc. | Infused wound care dressings |
WO2004071542A1 (en) * | 2003-02-14 | 2004-08-26 | The North West London Hospitals Nhs Trust | Bioactive material for use in stimulating vascularization |
US20060142413A1 (en) * | 2003-02-25 | 2006-06-29 | Jose Zimmer | Antimicrobial active borosilicate glass |
US8080490B2 (en) | 2003-02-25 | 2011-12-20 | Schott Ag | Antimicrobial phosphate glass |
DE10316156B3 (en) * | 2003-04-09 | 2004-10-14 | Beiersdorf Ag | Antimicrobial polymer materials and their use as a wound dressing |
WO2004103333A1 (en) * | 2003-05-24 | 2004-12-02 | Juvena (International) Ag | Tissue culture media used as a component of cosmetics |
WO2005027808A1 (en) | 2003-09-12 | 2005-03-31 | Z-Medica Corporation | Calcium zeolite hemostatic agent |
WO2005027834A2 (en) | 2003-09-12 | 2005-03-31 | Z-Medica Corporation | Partially hydrated hemostatic agent |
RU2378023C2 (en) * | 2003-12-19 | 2010-01-10 | Новамин Текнолоджи Инк. | Compositions and methods for prevention or reduction of dental deposit and/or gingivitis |
US7189263B2 (en) | 2004-02-03 | 2007-03-13 | Vita Special Purpose Corporation | Biocompatible bone graft material |
US9220595B2 (en) | 2004-06-23 | 2015-12-29 | Orthovita, Inc. | Shapeable bone graft substitute and instruments for delivery thereof |
EP1655042A1 (en) * | 2004-11-02 | 2006-05-10 | Vivoxid Oy | A medical device |
CA2594859C (en) | 2005-01-14 | 2013-08-13 | Henkel Kommanditgesellschaft Auf Atkien | Radiopaque cyanoacrylate compositions |
US20060178609A1 (en) | 2005-02-09 | 2006-08-10 | Z-Medica, Llc | Devices and methods for the delivery of molecular sieve materials for the formation of blood clots |
JP2008531498A (en) | 2005-02-15 | 2008-08-14 | バージニア コモンウェルス ユニバーシティ | Mineral technology (MT) for emergency hemostasis and treatment of acute wounds and chronic ulcers |
US9326995B2 (en) | 2005-04-04 | 2016-05-03 | The Regents Of The University Of California | Oxides for wound healing and body repair |
US7754194B2 (en) * | 2005-04-06 | 2010-07-13 | L'oréal | Hair relaxer compositions utilizing bioactive glass |
US8277837B2 (en) | 2006-01-11 | 2012-10-02 | Entegrion, Inc. | Hemostatic textile |
US8938898B2 (en) | 2006-04-27 | 2015-01-27 | Z-Medica, Llc | Devices for the identification of medical products |
US20070276308A1 (en) * | 2006-05-26 | 2007-11-29 | Huey Raymond J | Hemostatic agents and devices for the delivery thereof |
US8202532B2 (en) | 2006-05-26 | 2012-06-19 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
US7604819B2 (en) | 2006-05-26 | 2009-10-20 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
US7968114B2 (en) | 2006-05-26 | 2011-06-28 | Z-Medica Corporation | Clay-based hemostatic agents and devices for the delivery thereof |
WO2008002682A2 (en) | 2006-06-29 | 2008-01-03 | Orthovita, Inc. | Bioactive bone graft substitute |
US7879798B1 (en) | 2007-08-24 | 2011-02-01 | Regenicel, Inc. | Composition for indolent wound healing and methods of use therefor |
AR076178A1 (en) | 2009-04-01 | 2011-05-26 | Colgate Palmolive Co | DOUBLE ACTION DENTIFRIC COMPOSITIONS TO PREVENT HYPERSENSITIVITY AND PROMOTE REMINERALIZATION |
TWI391148B (en) | 2009-04-01 | 2013-04-01 | Colgate Palmolive Co | Non-aqueous dentifrice composition with bioacceptable and bioactive glass and methods of use and manufacture thereof |
US8778378B2 (en) | 2009-12-21 | 2014-07-15 | Orthovita, Inc. | Bioactive antibacterial bone graft materials |
US8858969B2 (en) | 2010-09-22 | 2014-10-14 | Z-Medica, Llc | Hemostatic compositions, devices, and methods |
US20130202670A1 (en) | 2012-02-03 | 2013-08-08 | Orthovita, Inc. | Bioactive antibacterial bone graft materials containing silver |
JP6001169B2 (en) | 2012-06-22 | 2016-10-05 | ゼット−メディカ,エルエルシー | Hemostatic device |
PT106679B (en) | 2012-11-27 | 2015-03-25 | Hovione Farmaciencia Sa | TOPICAL FORMULATIONS OF TETRACYCLINES, THEIR PREPARATION AND USES |
EP3013294B1 (en) | 2013-06-28 | 2019-09-25 | 3M Innovative Properties Company | Fibrin-coated wound dressing |
CN104258453A (en) * | 2014-09-24 | 2015-01-07 | 湖北华中医用材料有限公司 | Raw material composition of active wound repair material and preparation method of raw material composition |
KR101530574B1 (en) * | 2015-01-21 | 2015-06-22 | 서충은 | Composition for treatment of bedsore and burn |
US10059621B2 (en) | 2016-05-27 | 2018-08-28 | Corning Incorporated | Magnetizable glass ceramic composition and methods thereof |
US10751367B2 (en) | 2016-05-27 | 2020-08-25 | Corning Incorporated | Bioactive glass microspheres |
US10647962B2 (en) | 2016-05-27 | 2020-05-12 | Corning Incorporated | Bioactive aluminoborate glasses |
US20170342383A1 (en) | 2016-05-27 | 2017-11-30 | Corning Incorporated | Lithium disilicate glass-ceramic compositions and methods thereof |
US10676713B2 (en) | 2016-05-27 | 2020-06-09 | Corning Incorporated | Bioactive borophosphate glasses |
CN105999392A (en) * | 2016-07-01 | 2016-10-12 | 广州华弘生物科技有限公司 | Skin wound active dressing containing glass inorganic active materials |
CN107693833A (en) * | 2017-10-18 | 2018-02-16 | 张家港蓝智生物科技有限公司 | A kind of dispel scar moist dressing and preparation method containing bioactivity glass |
TWI794344B (en) | 2017-11-28 | 2023-03-01 | 美商康寧公司 | Chemically strengthened bioactive glass-ceramics |
CN111405913A (en) | 2017-11-28 | 2020-07-10 | 康宁股份有限公司 | Bioactive glass compositions and dentinal hypersensitivity repair |
WO2019108557A1 (en) | 2017-11-28 | 2019-06-06 | Corning Incorporated | Bioactive borate glass and methods thereof |
EP3717427A1 (en) | 2017-11-28 | 2020-10-07 | Corning Incorporated | High liquidus viscosity bioactive glass |
CN110680832B (en) * | 2018-07-04 | 2021-05-14 | 北京幸福益生高新技术有限公司 | Wound tissue self-derived regeneration and repair ointment and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4103002A (en) * | 1977-02-08 | 1978-07-25 | Board Of Regents, University Of Florida | Bioglass coated A1203 ceramics |
US5000746A (en) * | 1987-08-11 | 1991-03-19 | Friedrichsfeld Gmbh Keramik- Und Kunststoffwerke | Wound covering having connected discrete elements |
US5352715A (en) * | 1992-02-28 | 1994-10-04 | Collagen Corporation | Injectable ceramic compositions and methods for their preparation and use |
US5591453A (en) * | 1994-07-27 | 1997-01-07 | The Trustees Of The University Of Pennsylvania | Incorporation of biologically active molecules into bioactive glasses |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4303066A (en) | 1979-06-28 | 1981-12-01 | National Patent Development Corporation | Burn dressing |
US4272518A (en) | 1979-07-10 | 1981-06-09 | Moro Daniel G | Plastic wound bandage |
US5017627A (en) | 1980-10-09 | 1991-05-21 | National Research Development Corporation | Composite material for use in orthopaedics |
DE3270438D1 (en) | 1981-09-30 | 1986-05-15 | Leipzig Arzneimittel | Absorbent wound dressing and processes for its production |
US4538603A (en) | 1982-04-22 | 1985-09-03 | E. R. Squibb & Sons, Inc. | Dressings, granules, and their use in treating wounds |
ES8507345A1 (en) | 1982-12-02 | 1985-09-01 | Wallone Region | Bioreactive materials |
US4539200A (en) | 1983-11-04 | 1985-09-03 | The Kendall Company | Treatment of skin lesions |
GB2150833B (en) | 1983-12-08 | 1987-04-15 | Ceskoslovenska Akademie Ved | Proteolytic wounds dressing |
US4837285A (en) | 1984-03-27 | 1989-06-06 | Medimatrix | Collagen matrix beads for soft tissue repair |
US4851046A (en) * | 1985-06-19 | 1989-07-25 | University Of Florida | Periodontal osseous defect repair |
US4743229A (en) * | 1986-09-29 | 1988-05-10 | Collagen Corporation | Collagen/mineral mixing device and method |
US5263992A (en) | 1986-10-17 | 1993-11-23 | Bio-Metric Systems, Inc. | Biocompatible device with covalently bonded biocompatible agent |
US5126141A (en) | 1988-11-16 | 1992-06-30 | Mediventures Incorporated | Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides |
JPH0629126B2 (en) | 1989-03-29 | 1994-04-20 | 京都大学長 | Coating method of bioactive hydroxyapatite film |
US5298260A (en) | 1990-05-01 | 1994-03-29 | Mediventures, Inc. | Topical drug delivery with polyoxyalkylene polymer thermoreversible gels adjustable for pH and osmolality |
US5410016A (en) | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US5340776A (en) | 1991-01-11 | 1994-08-23 | Schott Glaswerke | Preparation of very fine glass powder of high purity |
JP3057773B2 (en) | 1991-02-05 | 2000-07-04 | 不二製油株式会社 | Pie making method |
US5766611A (en) | 1991-02-22 | 1998-06-16 | Ishizuka Garasu Kabushiki Kaisha | Cosmetic products containing a soluble glass |
EP0584372A1 (en) * | 1992-02-28 | 1994-03-02 | NIPPON ELECTRIC GLASS COMPANY, Limited | Bioactive cement |
US5696169A (en) | 1992-03-13 | 1997-12-09 | Otsuka Pharmaceutical Co., Ltd. | Antibacterial and antifungal activity method, therapeutic method of infectious diseases and preserving method of cosmetics |
US5681575A (en) | 1992-05-19 | 1997-10-28 | Westaim Technologies Inc. | Anti-microbial coating for medical devices |
JP3310291B2 (en) | 1992-08-13 | 2002-08-05 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | Bioactive substance template for in vitro synthesis of bone tissue |
CN1087279A (en) * | 1992-11-27 | 1994-06-01 | 中国科学院光电技术研究所 | Bio-active devitroceram artificial and method for making thereof |
US5807641A (en) | 1993-05-31 | 1998-09-15 | Sumitomo Osaka Cement Co., Ltd. | Anti-bacterial and anti-fungal glaze composition for ceramic products |
US5501706A (en) * | 1994-11-29 | 1996-03-26 | Wildflower Communications, Inc. | Medical implant structure and method for using the same |
US5728753A (en) | 1995-11-09 | 1998-03-17 | University Of London | Bioactive composite material for repair of hard and soft tissues |
US5681872A (en) * | 1995-12-07 | 1997-10-28 | Orthovita, Inc. | Bioactive load bearing bone graft compositions |
US5840290A (en) | 1996-05-30 | 1998-11-24 | University Of Florida Research Foundation | Injectable bio-active glass in a dextran suspension |
US5834008A (en) | 1996-09-19 | 1998-11-10 | U.S. Biomaterials Corp. | Composition and method for acceleration of wound and burn healing |
-
1996
- 1996-09-19 US US08/715,911 patent/US5834008A/en not_active Expired - Lifetime
-
1997
- 1997-09-19 DE DE69738693T patent/DE69738693D1/en not_active Expired - Lifetime
- 1997-09-19 EP EP97941714A patent/EP1021148B1/en not_active Expired - Lifetime
- 1997-09-19 AU AU43566/97A patent/AU4356697A/en not_active Abandoned
- 1997-09-19 JP JP51492898A patent/JP2001503739A/en not_active Ceased
- 1997-09-19 WO PCT/US1997/016732 patent/WO1998011853A1/en active Application Filing
- 1997-09-19 AT AT97941714T patent/ATE395022T1/en not_active IP Right Cessation
- 1997-09-19 CN CNB971915245A patent/CN1303953C/en not_active Expired - Fee Related
-
1998
- 1998-10-01 US US09/164,293 patent/US6428800B2/en not_active Expired - Lifetime
-
1999
- 1999-08-16 HK HK99103555A patent/HK1018394A1/en not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4103002A (en) * | 1977-02-08 | 1978-07-25 | Board Of Regents, University Of Florida | Bioglass coated A1203 ceramics |
US5000746A (en) * | 1987-08-11 | 1991-03-19 | Friedrichsfeld Gmbh Keramik- Und Kunststoffwerke | Wound covering having connected discrete elements |
US5352715A (en) * | 1992-02-28 | 1994-10-04 | Collagen Corporation | Injectable ceramic compositions and methods for their preparation and use |
US5591453A (en) * | 1994-07-27 | 1997-01-07 | The Trustees Of The University Of Pennsylvania | Incorporation of biologically active molecules into bioactive glasses |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6428800B2 (en) | 1996-09-19 | 2002-08-06 | Usbiomaterials Corporation | Composition and method for acceleration of wound and burn healing |
US6756060B1 (en) * | 1996-09-19 | 2004-06-29 | Usbiomaterials Corp. | Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
EP1049457A1 (en) * | 1998-01-23 | 2000-11-08 | Usbiomaterials Corporation | Bioactive glass treatment of inflammation in skin conditions |
EP1049457A4 (en) * | 1998-01-23 | 2006-05-24 | Usbiomaterials Corp | Bioactive glass treatment of inflammation in skin conditions |
WO2000015167A1 (en) * | 1998-09-10 | 2000-03-23 | Usbiomaterials Corporation | Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
EP2338448A3 (en) * | 1998-09-10 | 2013-12-11 | USBiomaterials Corporation | Anti-inflammatory and antimicrobial uses for bioactive glass |
JP2002524203A (en) * | 1998-09-10 | 2002-08-06 | ユーエスバイオマテリアルズ コーポレイション | Anti-inflammatory and antibacterial uses of bioactive glass compositions |
US6663878B1 (en) | 1999-04-29 | 2003-12-16 | Usbiomaterials Corp. | Anti-inflammatory bioactive glass particulates |
EP1185247A4 (en) * | 1999-04-29 | 2008-09-17 | Usbiomaterials Corp | Anti-inflammatory bioactive glass particulates |
EP1185247A1 (en) * | 1999-04-29 | 2002-03-13 | Usbiomaterials Corporation | Anti-inflammatory bioactive glass particulates |
US6482444B1 (en) | 1999-06-14 | 2002-11-19 | Imperial College Innovations | Silver-containing, sol/gel derived bioglass compositions |
US7628997B1 (en) | 1999-07-09 | 2009-12-08 | Schott Ag | Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations |
US7250174B2 (en) | 1999-12-07 | 2007-07-31 | Schott Ag | Cosmetic, personal care, cleaning agent, and nutritional supplement compositions and methods of making and using same |
JP2004500404A (en) * | 2000-03-27 | 2004-01-08 | カール − ツァイス − シュティフツング | Novel cosmetic, body care, cleansing and nutritional supplement compositions containing bioactive glass and methods of manufacture and use thereof |
ES2181593A1 (en) * | 2001-06-14 | 2003-02-16 | Univ Madrid Complutense | Method for producing bioactive implants that are used as systems for the controlled release of antibiotics |
WO2002102430A1 (en) * | 2001-06-14 | 2002-12-27 | Universidad Complutense De Madrid Rectorado | Method for producing bioactive implants that are used as systems for the controlled release of antibiotics |
JP2007507426A (en) * | 2003-09-29 | 2007-03-29 | ショット アクチエンゲゼルシャフト | Tissue abrasive |
WO2007072065A2 (en) * | 2005-12-23 | 2007-06-28 | Advanced Bio-Technologies, Inc. | Silicone composition |
WO2007072065A3 (en) * | 2005-12-23 | 2007-10-04 | Advanced Bio Technologies Inc | Silicone composition |
Also Published As
Publication number | Publication date |
---|---|
EP1021148A4 (en) | 2006-02-01 |
EP1021148B1 (en) | 2008-05-14 |
JP2001503739A (en) | 2001-03-21 |
ATE395022T1 (en) | 2008-05-15 |
AU4356697A (en) | 1998-04-14 |
US5834008A (en) | 1998-11-10 |
CN1208338A (en) | 1999-02-17 |
US6428800B2 (en) | 2002-08-06 |
HK1018394A1 (en) | 1999-12-24 |
EP1021148A1 (en) | 2000-07-26 |
DE69738693D1 (en) | 2008-06-26 |
US20010041186A1 (en) | 2001-11-15 |
CN1303953C (en) | 2007-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5834008A (en) | Composition and method for acceleration of wound and burn healing | |
US6756060B1 (en) | Anti-inflammatory and antimicrobial uses for bioactive glass compositions | |
JP5788323B2 (en) | Interfacial layer wound dressing | |
CA2343223C (en) | Anti-inflammatory and antimicrobial uses for bioactive glass compositions | |
US7196054B1 (en) | Methods for treating wound tissue and forming a supplemented fibrin matrix | |
USRE39192E1 (en) | Supplemented and unsupplemented tissue sealants, methods of their production and use | |
USRE39321E1 (en) | Supplemented and unsupplemented tissue sealants, methods of their production and use | |
US6197325B1 (en) | Supplemented and unsupplemented tissue sealants, methods of their production and use | |
EP0830381A1 (en) | Chitin hydrogels, methods of their production and use | |
TW200914035A (en) | Wound healing with zeolite-based hemostatic devices | |
KR20120138742A (en) | Use of synthetic polysulphated oligosaccharides as cleaning agents for a wound | |
Witkowski et al. | Debridement of cutaneous ulcers: medical and surgical aspects | |
Moore | Compromised wound healing: a scientific approach to treatment | |
RU2789304C1 (en) | Biodegradable wound-healing film | |
WO2019152640A1 (en) | Unique combination of natural biopolymers for advanced wound dressing | |
Lu et al. | Collagen-based drug delivery devices | |
CN112891607A (en) | Anti-infection and anti-adhesion modified chitosan hemostatic dressing and preparation method thereof | |
Jeffery et al. | Hemostatic and healing studies of sodium amylose succinate (IP760) | |
IL212052A (en) | Interface layer wound dressing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 97191524.5 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 1998 514928 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997941714 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1997941714 Country of ref document: EP |